Table 2 Outcome measures – mean scores (−/+ 95%CI) baseline to 12 months

ODI (0 to 100)

WG

20.5 (18.4 to 22.6)

15.1 (12.9 to 17.4)

13.1 (10.9 to 15.4)

11.9 (9.3 to 14.4)

SG

21.2 (18.7 to 23.8)

18.8 (15.8 to 21.8)

16.8 (13.5 to 20.1)

16.7 (11.9 to 21.4)

IPAQ (met-minutes/week)

WG

2864 (2201 to 3470)

3212 (2645 to 3779)

2494 (1906 to 3082)

2658 (1844 to 3472)

SG

3462 (2261 to 4662)

2322 (1484 to 3159)

1799 (1272 to 2327)

3016 (1671 to 4361)

FABQ (0 to 96)

WG

24.7 (22.8 to 26.6)

19.1 (16.7 to 21.4)

18.8 (15.7 to 21.9)

16.7 (13.7 to 19.6)

SG

24.8 (22.0 to 27.7)

22.6 (19.3 to 26.0)

19.8 (15.8 to 23.8)

18.3 (14.4 to 22.1)

FABQ (W) (0 to 42)

WG

14.1 (12.5 to 15.6)

11.1 (9.3 to 12.9)

10.6 (8.5 to 12.8)

9.7 (7.7 to 11.8)

SG

12.6 (10.2 to 15.0)

11.2 (8.4 to 13.9)

11.1 (7.8 to 14.4)

8.4 (5.4 to 11.5)

FABQ (PA) (0 to 24)

WG

10.7 (9.7 to 11.6)

8.0 (6.9 to 9.0)

8.0 (6.8 to 9.3)

6.9 (5.6 to 8.2)

SG

12.2 (10.7 to 13.7)

11.7 (9.8 to 13.6)

8.7 (6.8 to 10.5)

9.8 (7.6 to 12.0)

BBQ (9 to 45)

WG

30.5 (29.2 to 31.8)

31.6 (30.2 to 33.1)

31.7 (29.8 to 33.7)

31.8 (30.1 to 33.6)

SG

29.1 (27.5 to 30.6)

30.5 (28.7 to 32.3)

30.2 (27.3 to 33.1)

32.3 (29.8 to 34.8)

ODQ Pain Rating (0 to 5)

WG

1.1 (0.9 to 1.3)

1.0 (0.9 to 1.2)

0.9 (0.8 to 1.1)

0.9 (0.7 to 1.1)

SG

1.2 (1.0 to 1.4)

1.4 (1.1 to 1.7)

1.2 (0.8 to 1.5)

1.3 (0.9 to 1.7)

EQ-5D-5L (range − 0.148 to 0.949)

WG

0.798 (0.781 to 0.815)

0.832 (0.762 to 0.811)

0.844 (0.823 to 0.864)

0.846 (0.823 to 0.868)

SG

0.769 (0.746 to 0.793)

0.787 (0.762 to 0.811)

0.810 (0.779 to 0.841)

0.812 (0.773 to 0.852)

Self Efficacy Scale (1 to 25)

WG

16.0 (15.3 to 16.8)

15.1 (12.8 to 17.3)

15.2 (14.2 to 16.2)

15.9 (15.0 to 16.9)

SG

14.6 (13.7 to 15.4)

15.0 (13.8 to 16.2)

13.5 (11.8 to 15.3)

14.9 (13.8 to 16.0)